logo

For the Inventor, By the Inventor

Shelton, CT, United States of America

Markus Kristofer Dahlgren

This inventor holds 8 USPTO granted patents and 3 published patent applications and 2 EPO patents. Top assignees: D.e. Shaw Research, LLC, Hibercell, Inc., Relay Therapeutics, Inc.. Active years: 2020-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Markus Kristofer Dahlgren. Retrieved from https://idiyas.com/inventor/markus-kristofer-dahlgren

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 8 

% Patents Active = 100.0

 

Average Co-Inventor Count = 11.1

ph-index = 3

Forward Citations = 10(Granted Patents)


Company Filing History:

goldMedal3 out of 31 
 
D.e. Shaw Research, LLC
 patents
silverMedal3 out of 10 
 
Hibercell, Inc.
 patents
bronzeMedal3 out of 14 
 
Relay Therapeutics, Inc.
 patents
4. 1 out of 2,405 
 
Merck Sharp + Dohme Corp.
 patents
5. 1 out of 4 
 
Petra Pharma Corporation
 patents
where one patent can have more than one assignee

Years Active: 2020-2024

Loading Chart...
Loading Chart...
8 patents (USPTO):Explore Patents
1. 11919902 - Aryl-bipyridine amine derivatives as phosphatidylinositol phosphate kinase inhibitors (2024-03-05),
2. 11701354 - Pyrazolo[3,4-b]pyrazine derivatives as SHP2 phosphatase inhibitors (2023-07-18),
3. 11667651 - Aminopyridine derivatives as phosphatidylinositol phosphate kinase inhibitors (2023-06-06),
4. 11649227 - Allosteric chromenone inhibitors of phosphoinositide 3-kinase (PI3K) for the treatment of disease (2023-05-16),
5. 11629145 - SHP2 phosphatase inhibitors and methods of use thereof (2023-04-18),
6. 11591336 - Substituted pyrazolo[3,4-b]pyrazines as SHP2 phosphatase inhibitors (2023-02-28),
7. 11584763 - Chromenopyridine derivatives as phosphatidylinositol phosphate kinase inhibitors (2023-02-21),
8. 10875851 - Factor XIIa inhibitors (2020-12-29),

Title: Innovations and Contributions of Markus Kristofer Dahlgren

Introduction

Markus Kristofer Dahlgren is a notable inventor based in Shelton, CT (US). He has made significant contributions to the field of biochemistry and pharmacology, holding a total of 8 patents. His work primarily focuses on developing inhibitors that have potential therapeutic applications in various diseases.

Latest Patents

Dahlgren's latest patents include innovative compounds such as aryl-bipyridine amine derivatives, which serve as phosphatidylinositol phosphate kinase inhibitors. This invention is particularly relevant for treating cancers, neurodegenerative diseases, inflammatory disorders, and metabolic diseases. Another significant patent involves pyrazolo[3,4-b]pyrazine derivatives that act as SHP2 phosphatase inhibitors. These compounds are crucial in regulating cellular biological activities through intracellular signaling processes initiated by extracellular signals.

Career Highlights

Throughout his career, Markus Kristofer Dahlgren has worked with prominent companies in the biotechnology sector, including D.E. Shaw Research, LLC and Relay Therapeutics, Inc. His expertise in the field has allowed him to contribute to groundbreaking research and development projects.

Collaborations

Dahlgren has collaborated with esteemed colleagues such as Sathesh P Bhat and Edward A Kesicki, further enhancing the impact of his work in the scientific community.

Conclusion

Markus Kristofer Dahlgren's innovative contributions and patents reflect his dedication to advancing medical science and improving therapeutic options for various diseases. His work continues to inspire future research and development in the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…